Avadel Pharmaceuticals PLC (STU:AWK)
€ 10 0.15 (1.52%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.69 GF Score: 42/100

Avadel Pharmaceuticals PLC at Ladenburg Thalmann Healthcare Conference Transcript

Sep 24, 2019 / 04:00PM GMT
Release Date Price: €3.82 (-0.52%)
Unidentified Analyst

My name's [Raymond], and I'm part of the health care research team at Ladenburg Thalmann. And it's my pleasure to welcome Avadel Pharmaceuticals, so.

Gregory J. Divis
Avadel Pharmaceuticals plc - CEO & Director

Thank you, [Raymond]. Good afternoon, everyone. We certainly appreciate the opportunity from Ladenburg to be here and to present, and to give an update on the company. We've had a, what I would characterize as a pretty busy 24 hours with some of our news we announced just yesterday. But a very busy last 9 or 10 months as we've really worked hard to reposition the company in a new go-forward strategy.

During the course of the next few minutes, I would like to spend some time and tell you a little bit about what we've been up to, what we've worked on and what we've accomplished over the last 9 or -- 8, 9, 10 months, spend a little bit of time on our FT218 program and then wrap up a little bit in terms of some key milestones for the balance of this year. And then of course, we'll answer questions. I'm here with Dr. Jordan Dubow,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot